Release of Amyloid Beta-protein Precursor Derivatives by Electrical Depolarization of Rat Hippocampal Slices

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1993 Jun 1

PMID 8506366

Citations 66

Authors

R M Nitsch

S A Farber

J H Growdon

R J Wurtman

Affiliations

Soon will be listed here.

Abstract

Proteolytic processing of the beta-amyloid protein precursor (APP) is regulated by cell-surface receptors. To determine whether neurotransmitter release in response to neuronal activation regulates APP processing in brain, we electrically depolarized superfused rat hippocampal slices and measured soluble APP derivatives released into the superfusate. Electrical depolarization caused a rapid increase in the release of both neurotransmitters and amino-terminal APP cleavage products. These derivatives lacked the APP carboxyl terminus and were similar to those found in both cell culture media and human cerebrospinal fluid. Superfusate proteins including lactate dehydrogenase were not changed by electrical depolarization. The release of amino-terminal APP derivatives increased with increasing stimulation frequencies from 0 to 30 Hz. The increased release was inhibited by the sodium-channel antagonist tetrodotoxin, suggesting that action-potential formation mediates the release of large amino-terminal APP derivatives. These results suggest that neuronal activity regulates APP processing in the mammalian brain.

Citing Articles

Pharmacological enhancement of slow-wave activity at an early disease stage improves cognition and reduces amyloid pathology in a mouse model of Alzheimer's disease.

Kollarik S, Bimbiryte D, Sethi A, Dias I, Moreira C, Noain D Front Aging Neurosci. 2025; 16():1519225.

PMID: 39831085 PMC: 11739298. DOI: 10.3389/fnagi.2024.1519225.

Revealing excitation-inhibition imbalance in Alzheimer's disease using multiscale neural model inversion of resting-state functional MRI.

Li G, Hsu L, Wu Y, Bozoki A, Shih Y, Yap P Commun Med (Lond). 2025; 5(1):17.

PMID: 39814858 PMC: 11735810. DOI: 10.1038/s43856-025-00736-7.

Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease.

Morrone C, Raghuraman R, Hussaini S, Yu W Mol Neurodegener. 2023; 18(1):27.

PMID: 37085942 PMC: 10119020. DOI: 10.1186/s13024-023-00617-4.

Effects of DDT on Amyloid Precursor Protein Levels and Amyloid Beta Pathology: Mechanistic Links to Alzheimer's Disease Risk.

Eid A, Mhatre-Winters I, Sammoura F, Edler M, von Stein R, Hossain M Environ Health Perspect. 2022; 130(8):87005.

PMID: 35946953 PMC: 9364816. DOI: 10.1289/EHP10576.

Invited Perspective: Long-Lasting Legacy of Banned Contaminants in Alzheimer's Disease Etiology-Convergence of Epidemiological and Toxicological Findings.

Cannon J Environ Health Perspect. 2022; 130(8):81303.

PMID: 35946939 PMC: 9364815. DOI: 10.1289/EHP11650.

References

Nakanishi S . Molecular diversity of glutamate receptors and implications for brain function. Science. 1992; 258(5082):597-603. DOI: 10.1126/science.1329206. View

Nitsch R, Slack B, Wurtman R, Growdon J . Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science. 1992; 258(5080):304-7. DOI: 10.1126/science.1411529. View

Shoji M, Golde T, Ghiso J, Cheung T, Estus S, Shaffer L . Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 1992; 258(5079):126-9. DOI: 10.1126/science.1439760. View

Schwartzkroin P . Characteristics of CA1 neurons recorded intracellularly in the hippocampal in vitro slice preparation. Brain Res. 1975; 85(3):423-36. DOI: 10.1016/0006-8993(75)90817-3. View

Maire J, Wurtman R . Effects of electrical stimulation and choline availability on the release and contents of acetylcholine and choline in superfused slices from rat striatum. J Physiol (Paris). 1985; 80(3):189-95. View

Koh J, Choi D . Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods. 1987; 20(1):83-90. DOI: 10.1016/0165-0270(87)90041-0. View

Selkoe D, Podlisny M, Joachim C, Vickers E, Lee G, Fritz L . Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A. 1988; 85(19):7341-5. PMC: 282182. DOI: 10.1073/pnas.85.19.7341. View

Jan L, Jan Y . Voltage-sensitive ion channels. Cell. 1989; 56(1):13-25. DOI: 10.1016/0092-8674(89)90979-3. View

Weidemann A, Konig G, Bunke D, Fischer P, Salbaum J, Masters C . Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell. 1989; 57(1):115-26. DOI: 10.1016/0092-8674(89)90177-3. View

10.

Palmert M, Podlisny M, Witker D, Oltersdorf T, Younkin L, Selkoe D . The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc Natl Acad Sci U S A. 1989; 86(16):6338-42. PMC: 297834. DOI: 10.1073/pnas.86.16.6338. View

11.

Sisodia S, Koo E, Beyreuther K, Unterbeck A, Price D . Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 1990; 248(4954):492-5. DOI: 10.1126/science.1691865. View

12.

Esch F, Keim P, Beattie E, Blacher R, Culwell A, Oltersdorf T . Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 1990; 248(4959):1122-4. DOI: 10.1126/science.2111583. View

13.

Lonart G, Zigmond M . Incubation of tissue slices in the absence of Ca2+ and Mg2+ can cause nonspecific damage. J Neurochem. 1991; 56(4):1445-8. DOI: 10.1111/j.1471-4159.1991.tb11445.x. View

14.

Estus S, Golde T, Kunishita T, Blades D, Lowery D, Eisen M . Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science. 1992; 255(5045):726-8. DOI: 10.1126/science.1738846. View

15.

Golde T, Estus S, Younkin L, Selkoe D, Younkin S . Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science. 1992; 255(5045):728-30. DOI: 10.1126/science.1738847. View

16.

Kosik K . Alzheimer's disease: a cell biological perspective. Science. 1992; 256(5058):780-3. DOI: 10.1126/science.1589757. View

17.

Haass C, Koo E, Mellon A, Hung A, Selkoe D . Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature. 1992; 357(6378):500-3. DOI: 10.1038/357500a0. View

18.

Haass C, Schlossmacher M, Hung A, Mellon A, Ostaszewski B, Lieberburg I . Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 1992; 359(6393):322-5. DOI: 10.1038/359322a0. View

19.

Seubert P, Esch F, Lee M, Dovey H, Davis D, Sinha S . Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature. 1992; 359(6393):325-7. DOI: 10.1038/359325a0. View

20.

Buxbaum J, Oishi M, Chen H, Pinkas-Kramarski R, Jaffe E, Gandy S . Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc Natl Acad Sci U S A. 1992; 89(21):10075-8. PMC: 50280. DOI: 10.1073/pnas.89.21.10075. View